Menu
GeneBe

X-138710903-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_004114.5(FGF13):c.101G>C(p.Gly34Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 25)

Consequence

FGF13
NM_004114.5 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.870
Variant links:
Genes affected
FGF13 (HGNC:3670): (fibroblast growth factor 13) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked cognitive disability mapping to this region. Alternative splicing of this gene at the 5' end results in several transcript variants encoding different isoforms with different N-termini. [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM1
In a region_of_interest Mediates targeting to the nucleus (size 61) in uniprot entity FGF13_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_004114.5
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13043576).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FGF13NM_004114.5 linkuse as main transcriptc.101G>C p.Gly34Ala missense_variant 1/5 ENST00000315930.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FGF13ENST00000315930.11 linkuse as main transcriptc.101G>C p.Gly34Ala missense_variant 1/51 NM_004114.5 P4Q92913-1

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
25

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxAug 23, 2022Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
Cadd
Benign
22
Dann
Benign
0.83
DEOGEN2
Benign
0.22
T
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.042
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.34
N
MutationTaster
Benign
0.80
D;D;D;D;D
PROVEAN
Benign
-0.53
N
REVEL
Benign
0.17
Sift
Benign
0.071
T
Sift4G
Benign
0.74
T
Polyphen
0.0
B
Vest4
0.073
MutPred
0.11
Loss of relative solvent accessibility (P = 0.0676);
MVP
0.76
ClinPred
0.30
T
GERP RS
4.5
Varity_R
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-137793065; API